Plasma Urotensin II Concentration In Gestational Diabetes
نویسندگان
چکیده
منابع مشابه
Increased plasma urotensin II levels in patients with diabetes mellitus.
Urotensin II (UII) is the most potent vasoconstrictor peptide, whereas it acts as a vasodilator on some arteries. We studied plasma levels of UII in diabetic patients with normal serum creatinine levels (<90 micromol/l) and the expression of UII and its receptor in cultured human vascular endothelial cells. Plasma UII levels were significantly elevated by 1.8-fold in diabetic patients without p...
متن کاملMaternal Serum C- Reactive Protein Concentration in Gestational Diabetes
OBJECTIVE: Low-grade systemic inflammation is associated with an increased risk of type 2 diabetes. C-Reactive Protein (CRP), an acute phase protein produced by hepatocytes, may be associated with diabetes. This study aimed to compare serum levels of CRP in women with gestational diabetes mellitus (GDM), impaired glucose tolerance test and control subjects. MATERIALS AND METHODS: In this ca...
متن کاملIs plasma urotensin II concentration an indicator of myocardial damage in patients with acute coronary syndrome?
INTRODUCTION Urotensin II (UII) is a vasoactive peptide secreted by endothelial cells. Increased plasma UII concentration was observed in patients with heart failure, liver cirrhosis, diabetic nephropathy and renal insufficiency. In patients with myocardial infarction both increased and decreased plasma UII concentrations were demonstrated. The aim of this study was to analyze whether plasma UI...
متن کاملMaternal serum leptin concentration in gestational diabetes.
OBJECTIVE The aim of this study was to evaluate fasting serum leptin concentration and its relation to insulin resistance in women with gestational diabetes mellitus (GDM) and gestational impaired glucose tolerance (IGT). MATERIALS AND METHODS This case-control study, at 28 weeks of gestation, measured serum concentration of fasting leptin, insulin, and homeostatic model assessment index in t...
متن کاملHuman urotensin II in the plasma of anephric subjects.
to ESRF. After 3 years of the initial diagnosis, the patient underwent autologous PBSC transplantation using intermediate dose melphalan (100mg/m). IgG level fell to 300mg/dl, with serum kappa free light chains of 83.2mg/l (3.3–19.4). Severe neutropenic sepsis precluded a planned second PBSC transplant. A year later, the patient underwent HLA-identical living donor kidney transplantation. Post-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
سال: 2017
ISSN: 2564-6567
DOI: 10.25000/acem.336837